Volume 18, Number 11—November 2012
Research
Community Outbreak of Adenovirus, Taiwan, 2011
Table 3
Laboratory results and no. patients tested | All | Severe infection, n = 31 | Nonsevere infection, n = 171 | p value |
---|---|---|---|---|
Hemoglobin, g/dL (range), n = 201 | 11.7 | 9.7 (3.4–13.8) | 11.8 (7.0–14.6) | <0.001 |
Platelets, × 103/μL (range), n = 201 | 237 | 106 (11–340) | 251(14–555) | <0.001 |
Thrombocytopenia, no. (%) patients† |
43 (21) | 24 (77) | 19 (11) | <0.001 |
Leukocytes, × 103 cells/μL (range), n = 201 | 10.06 | 4.4 (1.2–10.3) | 11.3 (0.2–35.5) | <0.001 |
Leukopenia, no. (%) patients‡ |
28 (14) | 18 (58) | 10 (6) | <0.001 |
Sodium, mmol/L (range), n = 138 | 135 | 131 (119–137) | 135 (127–142) | <0.001 |
Hyponatremia, no. (%) patients§ | 68 (49) | 22 (81) | 46 (41) | <0.001 |
C-reactive protein, mg/dL (range), n = 200 | 4.15 | 6.1 (0.02–30.00) | 4.0 (0–47.2) | 0.086 |
LDH, U/L (range), n = 22 | 2,202 | 3,281 (1,029–9,782) | 937 (493–17,454) | 0.023 |
AST, U/L (range), n = 117 | 43 | 135 (38–3,520) | 38 (3.5–989) | <0.001 |
AST >2× upper limit, no. (%) patients |
36 (31) | 22 (85) | 14 (15) | <0.001 |
ALT, U/L (range), n = 104 | 26.5 | 67.5 (12.0–511.0) | 24 (8–652) | <0.001 |
ALT >2× upper limit, no. (%) patients |
24 (23) | 15 (58) | 9 (12) | <0.001 |
Creatinine, mg/dL (range), n = 155 | 0.61 | 0.68 (0.3–1.1) | 0.6 (0.2–0.9) | 0.088 |
*Severe infection indicates patients who were admitted to the intensive care unit. LDH, lactate dehydrogenase; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
†Platelet count <150,000/μL.
‡Leukocyte count <5,000 cells/μL.
§Serum sodium <135 mmol/L.
1These authors contributed equally to this article.
Page created: October 16, 2012
Page updated: October 16, 2012
Page reviewed: October 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.